This inventor holds 2 USPTO granted patents. Top assignees: Emory University, Trustees of the University of Penna., University of Pennsylvania. Active years: 1994-1996.
Company Filing History:
2 out of 1,023 
1 out of 7 
1 out of 2,651 
Years Active: 1994-1996
Title: The Innovative Mind of Paul M. Iuvone
Introduction
Paul M. Iuvone, an accomplished inventor based in DeKalb, GA, has made significant contributions to the field of ocular development through his patented innovations. With a focus on pharmacological treatments, he has developed methods that address crucial aspects of eye growth in maturing animals.
Latest Patents
Iuvone holds two notable patents that reveal his expertise in treating ocular conditions. The first patent details a method for controlling the abnormal postnatal growth of the eye through the ocular administration of therapeutically effective amounts of a dopamine antagonist. This innovative approach targets the mechanisms that contribute to abnormal eye growth. The second patent outlines a method for inhibiting abnormal postnatal axial growth of the eye. This technique involves identifying neurochemicals present in the retina, such as dopamine, which are often reduced under conditions leading to abnormal growth. Iuvone's approaches emphasize the critical roles of neurochemicals and their administration during postnatal maturation to promote healthy eye development.
Career Highlights
Throughout his career, Paul M. Iuvone has held positions at prestigious institutions including Emory University and the Trustees of the University of Pennsylvania. His work in these reputable organizations has contributed to his extensive knowledge and success in ocular research.
Collaborations
Iuvone has had the opportunity to collaborate with esteemed colleagues, including Richard A. Stone and Alan M. Laties. These collaborations have likely enriched his research and allowed for the exchange of innovative ideas in the field of ocular pharmacology.
Conclusion
Paul M. Iuvone's contributions through his patents demonstrate his dedication to advancing the understanding of ocular development. His innovative methods represent significant progress in addressing abnormal eye growth in maturing animals. His work continues to inspire researchers and inventors in the field of ocular health.